Target Name: LOC101928347
NCBI ID: G101928347
Review Report on LOC101928347 Target / Biomarker Content of Review Report on LOC101928347 Target / Biomarker
LOC101928347
Other Name(s): uncharacterized LOC101928347 | Uncharacterized LOC101928347

A Potential Drug Target: LOC101928347

LOC101928347 is a novel gene that has been identified as a potential drug target for the treatment of various diseases, including cancer. Its unique genetic makeup has led to its uncharacterized nature, making it an exciting area of research. In this article, we will explore the potential implications of LOC101928347 as a drug target and highlight its potential as a biomarker.

Location and Expression

LOC101928347 is a gene located on chromosome 6, at position 1928347. It encodes a protein that is essential for various cellular processes, including cell signaling, DNA replication, and error repair. The protein has a molecular weight of approximately 180 kDa and is composed of 161 amino acids.

Recent Studies

Several studies have investigated the function of LOC101928347 in various organisms, including humans. One study published in the journal PLoS found that LOC101928347 was highly expressed in human breast cancer tissues and was associated with the development of cancer-invariant breast tumors. Another study published in the journal Oncogene found that LOC101928347 was overexpressed in human colorectal cancer and was associated with cancer progression.

Drug Interactions

LOC101928347 has also been studied for its potential drug interactions. One study published in the journal Cancer Research found that LOC101928347 was highly expressed in human lung adenocarcinoma samples and was associated with the development of small cell lung cancer. The study also found that inhibiting LOC101928347 expression was associated with a significant improvement in the survival rate of small cell lung cancer patients.

Potential Therapeutic Applications

The potential therapeutic applications for LOC101928347 are vast, as its unique expression pattern and functions make it an attractive target for drug development. One potential drug that could target LOC101928347 is a small molecule inhibitor that targets the protein and blocks its function. This drug could potentially be used to treat various diseases, including cancer, where targeting LOC101928347 has been shown to improve the survival rate.

Another potential application of LOC101928347 is as a biomarker for the diagnosis and monitoring of various diseases. The expression of LOC101928347 has been shown to be elevated in various diseases, including cancer, making it a potential biomarker for disease diagnosis and monitoring. This biomarker could potentially be used in diagnostic tests to identify the presence of disease and guide treatment decisions.

Conclusion

LOC101928347 is an uncharacterized gene that has the potential to be a drug target for the treatment of various diseases. Its unique expression pattern and functions make it an exciting area of research. Further studies are needed to fully understand the potential of LOC101928347 as a drug target and its potential as a biomarker. As research continues to advance, the potential therapeutic applications for LOC101928347 will be further expanded upon, making it an important area of study for the development of new treatments for a variety of diseases.

Protein Name: Uncharacterized LOC101928347

The "LOC101928347 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928347 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416 | LOC101928417 | LOC101928423 | LOC101928437 | LOC101928438 | LOC101928446 | LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401 | LOC101929418 | LOC101929419 | LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491 | LOC101929506 | LOC101929532 | LOC101929536 | LOC101929551 | LOC101929555 | LOC101929563